TOP TIERMARKET NEWSWIRE
News & sentiment

INNOCAN PHARMA CORP (INNPF) — News & AI sentiment

INNOCAN PHARMA CORP (INNPF) news roundup. 4 stories aggregated over the last 30 days. Average 30-day sentiment is 35/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
4
avg sentiment 35/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

INNPF news in the last 24 hours, 7 days, 30 days and 90 days

How much INNPF coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowINNPF storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days435/100INNPF headlines →
Last 90 days645/100INNPF headlines →

Latest stories on INNPF

Sep 9
Sep 9
Innocan Pharma reports Q2 results
Seeking Alpha34 · bearishearnings
Aug 31
Aug 31
Aug 5
Jul 29
Innocan Pharma reports Q1 results
Seeking Alpha50 · neutralearnings
May 27
May 27
May 6
Open INNPF in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →